Lung cancer genes linked to dangerous blood clots in new study

NCT ID NCT07288632

Recruiting now Knowledge-focused Sponsor: University Of Perugia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 500 people with advanced lung cancer to see if certain genetic changes (mutations) increase the risk of blood clots. Researchers will measure blood markers and track participants for 6 months. The goal is to learn which patients are at higher risk so doctors can better prevent clots in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma venous thromboembolism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) VENOUS THROMBOEMBOLISM (VTE)

Contacts and locations

Locations

Emily Oliovecchio
RECRUITING

Perugia, Perugia, 06135, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.